在宿主内部的SARS-CoV-2流行病模型的参数可识别性
Junyuan Yang1,2, Sijin Wu2, Xuezhi Li3
1Complex Systems Research Center, Shanxi University, Taiyuan, 030006, China.
Infectious Disease Modelling
|June 17, 2024
概括
本研究使用DAISY和模拟来确定SARS-CoV-2 (COVID-19) 模型中的关键参数. 减少病毒复制和传染性对于控制COVID-19的传播至关重要.
科学领域:
- 流行病学 流行病学
- 数学建模的数学建模
- 病毒学 病毒学
背景情况:
- 了解SARS-CoV-2的动态对于有效的流行病控制至关重要.
- 参数识别对于完善流行病模型至关重要.
研究的目的:
- 在宿主内部的SARS-CoV-2模型中评估参数的结构识别性.
- 使用蒙特卡洛模拟和灵敏度分析分析模型参数.
主要方法:
- 使用DAISY算法进行结构识别分析.
- 执行蒙特卡洛模拟,用于实际的参数分析.
- 进行敏感性分析以确定有效的控制措施.
主要成果:
- 在SARS-CoV-2流行病模型中确定了关键参数.
- 敏感性分析强调了特定参数对疾病传播的影响.
- 证明减少病毒复制和传染期是有效的控制策略.
结论:
- 这项研究为SARS-CoV-2模型的参数识别提供了见解.
- 研究结果支持针对性的干预措施,以减轻COVID-19的传播.
- 基于模型的分析对于为公共卫生战略提供信息至关重要.
相关概念视频
Steps in Outbreak Investigation
122
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
122
Mechanistic Models: Compartment Models in Individual and Population Analysis
36
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
36
Causality in Epidemiology
383
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
383
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
115
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
115
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
464
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
464


